Sigilon Therapeutics, Inc.
SGTXDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821323
Sigilon Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 15, 2023; 16 institutions reported holding it in 13F filings for Q2 2023, worth $26.6M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Sigilon Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SGTX is no longer listed, so this page shows Q2 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 16
- −16 vs. Q1 2023
- Shares held
- 1.18M
- −180.9K (−13.3%) vs. Q1 2023Converted for a 1-for-13 split
- Total value
- $26.6M
- +$10.1M (+61.4%) vs. Q1 2023
- New holders
- 3
- 2 more added
- Sold out
- 19
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $4.49K |
| Q2 2023 | 16 | $26.6M |
| Q1 2023 | 32 | $16.5M |
| Q4 2022 | 32 | $6.12M |
| Q3 2022 | 33 | $8.50M |
| Q2 2022 | 37 | $14.2M |
| Q1 2022 | 48 | $26.8M |
| Q4 2021 | 50 | $52.2M |
| Q3 2021 | 45 | $109.0M |
| Q2 2021 | 52 | $209.2M |
| Q1 2021 | 52 | $438.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Sigilon Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 797,720 | $18.0M | 0.80% | 00.0% | UnchangedConverted for a 1-for-13 split |
| Canada Pension Plan Investment Board | 114,244 | $2.57M | 0.00% | 00.0% | UnchangedConverted for a 1-for-13 split |
| FMR LLC | 78,796 | $1.77M | 0.00% | −2,327−2.9% | ReducedConverted for a 1-for-13 split |
| HarbourVest Partners LLC | 56,979 | $1.28M | 0.36% | 00.0% | UnchangedConverted for a 1-for-13 split |
| Yakira Capital Management, Inc. | 39,746 | $894.7K | 0.24% | +39,746 | New |
| State of Wisconsin Investment Board | 39,202 | $882.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-13 split |
| Vanguard Group Inc | 23,144 | $521.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-13 split |
| CSS LLC | 13,292 | $299.2K | 0.02% | +13,292 | New |
| Bridgeway Capital Management, LLC | 9,615 | $216.4K | 0.01% | 00.0% | UnchangedConverted for a 1-for-13 split |
| Morgan Stanley | 6,418 | $144.5K | 0.00% | −12,569−66.2% | ReducedConverted for a 1-for-13 split |
| Tower Research Capital LLC (TRC) | 2,069 | $46.6K | 0.00% | +1,037+100.5% | AddedConverted for a 1-for-13 split |
| BlackRock Inc. | 253 | $5.70K | 0.00% | −80,452−99.7% | ReducedConverted for a 1-for-13 split |
| Royal Bank of Canada | 131 | $3.00K | 0.00% | +131 | New |
| Wells Fargo & Company | 8 | $180 | 0.00% | +0+1.0% | AddedConverted for a 1-for-13 split |
| Advisor Group Holdings, Inc. | 7 | $157 | 0.00% | −1−9.0% | ReducedConverted for a 1-for-13 split |
| Bank of America Corp | 1 | $23 | 0.00% | −681−99.9% | ReducedConverted for a 1-for-13 split |
| Cercano Management LLC | 0 | $0 | 0.00% | −68,071−100.0% | Sold outConverted for a 1-for-13 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −21,425−100.0% | Sold outConverted for a 1-for-13 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,031−100.0% | Sold outConverted for a 1-for-13 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −7,441−100.0% | Sold outConverted for a 1-for-13 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −7,423−100.0% | Sold outConverted for a 1-for-13 split |
| Choate Investment Advisors | 0 | $0 | 0.00% | −5,128−100.0% | Sold outConverted for a 1-for-13 split |
| State Street Corp | 0 | $0 | 0.00% | −3,177−100.0% | Sold outConverted for a 1-for-13 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −2,426−100.0% | Sold outConverted for a 1-for-13 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −2,200−100.0% | Sold outConverted for a 1-for-13 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,123−100.0% | Sold outConverted for a 1-for-13 split |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −1,972−100.0% | Sold outConverted for a 1-for-13 split |
| Soundmark Wealth Management, LLC | 0 | $0 | 0.00% | −1,966−100.0% | Sold outConverted for a 1-for-13 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,853−100.0% | Sold outConverted for a 1-for-13 split |
| Raymond James & Associates | 0 | $0 | 0.00% | −1,723−100.0% | Sold outConverted for a 1-for-13 split |
| Prudential Financial Inc | 0 | $0 | 0.00% | −815−100.0% | Sold outConverted for a 1-for-13 split |
| Barclays PLC | 0 | $0 | 0.00% | −180−100.0% | Sold outConverted for a 1-for-13 split |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −98−100.0% | Sold outConverted for a 1-for-13 split |
| UBS Group AG | 0 | $0 | 0.00% | −54−100.0% | Sold outConverted for a 1-for-13 split |
| New England Capital Financial Advisors LLC | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-13 split |